Reduced Albumin Concentration Predicts Weight Gain and Higher


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 16 12 2020
accepted: 25 01 2021
entrez: 29 3 2021
pubmed: 30 3 2021
medline: 15 1 2022
Statut: epublish

Résumé

Circulating albumin is negatively associated with adiposity but whether it is associated with increased energy intake, lower energy expenditure or weight gain has not been examined. In After adjustment for known determinants of energy intake lower plasma albumin concentration was associated with greater total daily energy intake (β= 89.8 kcal/day per 0.1 g/dl difference in plasma albumin, p=0.0047). No associations were observed between plasma albumin concentrations and 24-h energy expenditure or 24-h respiratory quotient (p>0.2). Over 6 years, volunteers gained on average 7.5 ± 11.7 kg (p<0.0001). Lower albumin concentrations were associated with greater weight [β=3.53 kg, p=0.039 (adjusted for age, sex, follow up time), CI 0.16 to 6.21 per 1 g/dl difference albumin concentration] and fat mass (β=2.3 kg, p=0.022), respectively, but not with changes in fat free mass (p=0.06). Lower albumin concentrations were associated with increased ClinicalTrials.gov, identifiers NCT00340132, NCT00342732.

Identifiants

pubmed: 33776937
doi: 10.3389/fendo.2021.642568
pmc: PMC7991842
doi:

Substances chimiques

Albumins 0
Ghrelin 0

Banques de données

ClinicalTrials.gov
['NCT00342732', 'NCT00340132']

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

642568

Subventions

Organisme : Intramural NIH HHS
ID : Z01 DK069091
Pays : United States

Informations de copyright

Copyright © 2021 Basolo, Ando, Chang, Hollstein, Krakoff, Piaggi and Votruba.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biochim Biophys Acta. 1999 Nov 23;1441(2-3):131-40
pubmed: 10570241
Diabetes. 2002 Feb;51(2):271-5
pubmed: 11812732
J Thromb Haemost. 2007 Aug;5(8):1637-43
pubmed: 17596140
Am J Clin Nutr. 1995 Oct;62(4):730-4
pubmed: 7572700
Mol Cell Endocrinol. 2016 Nov 15;436:130-40
pubmed: 27431015
Endocrinology. 2009 Sep;150(9):4124-34
pubmed: 19477937
Diabetol Metab Syndr. 2019 Feb 7;11:14
pubmed: 30774722
Am J Clin Nutr. 1979 Feb;32(2):418-26
pubmed: 420132
Am J Physiol. 1988 Sep;255(3 Pt 1):E332-7
pubmed: 3421330
Am J Epidemiol. 1978 Dec;108(6):497-505
pubmed: 736028
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
Int J Obes (Lond). 2014 Feb;38(2):243-51
pubmed: 23736368
Drug Metab Pharmacokinet. 2009;24(4):300-7
pubmed: 19745557
Nutrition. 2011 Feb;27(2):165-9
pubmed: 20418059
J Clin Endocrinol Metab. 1981 Jul;53(1):58-68
pubmed: 7195404
Nutrients. 2020 Oct 29;12(11):
pubmed: 33138134
J Am Heart Assoc. 2020 Feb 4;9(3):e014716
pubmed: 32009529
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460
IUBMB Life. 2005 Dec;57(12):787-96
pubmed: 16393781
Annu Rev Pharmacol Toxicol. 2005;45:119-46
pubmed: 15822173
Blood Transfus. 2009 Oct;7(4):268-77
pubmed: 20011638
J Clin Invest. 1986 Dec;78(6):1568-78
pubmed: 3782471
Aliment Pharmacol Ther. 2002 Dec;16 Suppl 5:6-11
pubmed: 12423448
J Am Diet Assoc. 2004 Aug;104(8):1258-64
pubmed: 15281044
Int J Obes (Lond). 2011 Mar;35(3):336-44
pubmed: 20714328
Am J Physiol Endocrinol Metab. 2013 Mar 1;304(5):E466-77
pubmed: 23269411
Am J Clin Nutr. 1991 Jun;53(6):1368-71
pubmed: 2035463
Obesity (Silver Spring). 2017 Feb;25(2):332-337
pubmed: 28000375
Lipids Health Dis. 2014 Feb 08;13:29
pubmed: 24507240
N Engl J Med. 2011 Feb 24;364(8):719-29
pubmed: 21345101
J Biol Chem. 1961 Dec;236:3163-7
pubmed: 13922531
Int J Obes Relat Metab Disord. 2004 Nov;28 Suppl 3:S59-63
pubmed: 15543221
Annu Rev Nutr. 1987;7:187-208
pubmed: 3300732
J Am Med Dir Assoc. 2007 Sep;8(7):458-63
pubmed: 17845949
Metabolism. 2018 May;82:65-71
pubmed: 29305947
Rev Endocr Metab Disord. 2015 Mar;16(1):47-54
pubmed: 25526866
Metabolism. 2018 Aug;85:116-125
pubmed: 29596853
Expert Rev Proteomics. 2017 Aug;14(8):677-689
pubmed: 28689445
Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E633-9
pubmed: 20647558
Nutrition. 1999 Sep;15(9):704-14
pubmed: 10467616
Nat Med. 2002 Jan;8(1):75-9
pubmed: 11786910
Am J Clin Nutr. 2010 Feb;91(2):343-8
pubmed: 19923376

Auteurs

Alessio Basolo (A)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.
Unit of Endocrinology, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.

Takafumi Ando (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.
Japan Society for the Promotion of Science, Tokyo, Japan.

Douglas C Chang (DC)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.

Tim Hollstein (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.

Jonathan Krakoff (J)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.

Paolo Piaggi (P)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.
Department of Information Engineering, University of Pisa, Pisa, Italy.

Susanne Votruba (S)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH